{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T21:03:01Z","timestamp":1774904581650,"version":"3.50.1"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2016,9,27]],"date-time":"2016-09-27T00:00:00Z","timestamp":1474934400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,9,27]],"date-time":"2016-09-27T00:00:00Z","timestamp":1474934400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1038\/pr.2016.191","type":"journal-article","created":{"date-parts":[[2016,9,27]],"date-time":"2016-09-27T16:03:39Z","timestamp":1474992219000},"page":"162-169","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Treatment of perinatal viral infections to improve neurologic outcomes"],"prefix":"10.1038","volume":"81","author":[{"given":"William J.","family":"Muller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,9,27]]},"reference":[{"key":"BFpr2016191_CR1","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1159\/000113493","volume":"61","author":"CB Wilson","year":"2008","unstructured":"Wilson CB, Kollmann TR. Induction of antigen-specific immunity in human neonates and infants. Nestle Nutr Workshop Ser Pediatr Program 2008;61:183\u201395.","journal-title":"Nestle Nutr Workshop Ser Pediatr Program"},{"key":"BFpr2016191_CR2","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/nri2075","volume":"7","author":"O Levy","year":"2007","unstructured":"Levy O. Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat Rev Immunol 2007;7:379\u201390.","journal-title":"Nat Rev Immunol"},{"key":"BFpr2016191_CR3","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1111\/j.1651-2227.2011.02494.x","volume":"101","author":"S Ygberg","year":"2012","unstructured":"Ygberg S, Nilsson A. The developing immune system - from foetus to toddler. Acta Pediatr 2012;101:120\u20137.","journal-title":"Acta Pediatr"},{"key":"BFpr2016191_CR4","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/S1473-3099(14)70710-8","volume":"14","author":"T Strunk","year":"2014","unstructured":"Strunk T, Inder T, Wang X, Burgner D, Mallard C, Levy O. Infection-induced inflammation and cerebral injury in preterm infants. Lancet Infect Dis 2014;14:751\u201362.","journal-title":"Lancet Infect Dis"},{"key":"BFpr2016191_CR5","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/S0140-6736(11)61577-8","volume":"379","author":"MK Mwaniki","year":"2012","unstructured":"Mwaniki MK, Atieno M, Lawn JE, Newton CR. Long-term neurodevelopmental outcomes after intrauterine and neonatal insults: a systematic review. Lancet 2012;379:445\u201352.","journal-title":"Lancet"},{"key":"BFpr2016191_CR6","doi-asserted-by":"publisher","first-page":"e1001158","DOI":"10.1371\/journal.pmed.1001158","volume":"9","author":"JG Berry","year":"2012","unstructured":"Berry JG, Poduri A, Bonkowsky JL, et al. Trends in resource utilization by children with neurological impairment in the United States inpatient health care system: a repeat cross-sectional study. PLoS Med 2012;9:e1001158.","journal-title":"PLoS Med"},{"key":"BFpr2016191_CR7","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1001\/jamapediatrics.2013.4342","volume":"168","author":"MJ Papania","year":"2014","unstructured":"Papania MJ, Wallace GS, Rota PA, et al. Elimination of endemic measles, rubella, and congenital rubella syndrome from the Western hemisphere: the US experience. JAMA Pediatr 2014;168:148\u201355.","journal-title":"JAMA Pediatr"},{"issue":"RR-04","key":"BFpr2016191_CR8","first-page":"1","volume":"62","author":"HQ McLean","year":"2013","unstructured":"McLean HQ, Fiebelkorn AP, Temte JL, Wallace GS ; Centers for Disease Control and Prevention. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2013;62(RR-04):1\u201334.","journal-title":"MMWR Recomm Rep"},{"key":"BFpr2016191_CR9","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1093\/infdis\/jiu456","volume":"210 Suppl 1","author":"SG Wassilak","year":"2014","unstructured":"Wassilak SG, Oberste MS, Tangermann RH, Diop OM, Jafari HS, Armstrong GL. Progress toward global interruption of wild poliovirus transmission, 2010\u20132013, and tackling the challenges to complete eradication. J Infect Dis 2014;210 Suppl 1:S5\u2013S15.","journal-title":"J Infect Dis"},{"key":"BFpr2016191_CR10","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1097\/INF.0b013e3181bbf2a0","volume":"29","author":"SS Shah","year":"2010","unstructured":"Shah SS, Wood SM, Luan X, Ratner AJ. Decline in varicella-related ambulatory visits and hospitalizations in the United States since routine immunization against varicella. Pediatr Infect Dis J 2010;29:199\u2013204.","journal-title":"Pediatr Infect Dis J"},{"key":"BFpr2016191_CR11","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1128\/br.28.4.458-471.1964","volume":"28","author":"TF Scott","year":"1964","unstructured":"Scott TF, Tokumaru T. Herpesvirus hominis (virus of herpes simplex). Bacteriol Rev 1964;28:458\u201371.","journal-title":"Bacteriol Rev"},{"key":"BFpr2016191_CR12","first-page":"127","volume":"11","author":"GM Hass","year":"1935","unstructured":"Hass GM. Hepato-adrenal necrosis with intranuclear inclusion bodies: report of a case. Am J Pathol 1935;11:127\u2013142.5.","journal-title":"Am J Pathol"},{"key":"BFpr2016191_CR13","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1001\/archopht.1962.00960030239015","volume":"68","author":"H Kaufman","year":"1962","unstructured":"Kaufman H, Martola EL, Dohlman C. Use of 5-iodo-2\u2032-deoxyuridine (IDU) in treatment of herpes simplex keratitis. Arch Ophthalmol 1962;68:235\u20139.","journal-title":"Arch Ophthalmol"},{"key":"BFpr2016191_CR14","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/S0022-3476(70)80346-8","volume":"77","author":"JC Overall Jr","year":"1970","unstructured":"Overall JC Jr, Glasgow LA. Virus infections of the fetus and newborn infant. J Pediatr 1970;77:315\u201333.","journal-title":"J Pediatr"},{"key":"BFpr2016191_CR15","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1093\/jac\/14.suppl_A.57","volume":"14 Suppl A","author":"RJ Whitley","year":"1984","unstructured":"Whitley RJ. Treatment of human herpesvirus infections with special reference to encephalitis. J Antimicrob Chemother 1984;14 Suppl A:57\u201374.","journal-title":"J Antimicrob Chemother"},{"key":"BFpr2016191_CR16","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1542\/peds.66.4.495","volume":"66","author":"RJ Whitley","year":"1980","unstructured":"Whitley RJ, Nahmias AJ, Soong SJ, Galasso GG, Fleming CL, Alford CA. Vidarabine therapy of neonatal herpes simplex virus infection. Pediatrics 1980;66:495\u2013501.","journal-title":"Pediatrics"},{"key":"BFpr2016191_CR17","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1542\/peds.72.6.778","volume":"72","author":"RJ Whitley","year":"1983","unstructured":"Whitley RJ, Yeager A, Kartus P, et al. Neonatal herpes simplex virus infection: follow-up evaluation of vidarabine therapy. Pediatrics 1983;72:778\u201385.","journal-title":"Pediatrics"},{"key":"BFpr2016191_CR18","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1056\/NEJM199102143240703","volume":"324","author":"R Whitley","year":"1991","unstructured":"Whitley R, Arvin A, Prober C, et al. A controlled trial comparing vidarabine with acyclovir in neonatal herpes simplex virus infection. Infectious diseases collaborative antiviral study group. N Engl J Med 1991;324:444\u20139.","journal-title":"N Engl J Med"},{"key":"BFpr2016191_CR19","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1542\/peds.108.2.230","volume":"108","author":"DW Kimberlin","year":"2001","unstructured":"Kimberlin DW, Lin CY, Jacobs RF, et al.; National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections. Pediatrics 2001;108:230\u20138.","journal-title":"Pediatrics"},{"key":"BFpr2016191_CR20","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1542\/peds.2004-0777","volume":"115","author":"M Fonseca-Aten","year":"2005","unstructured":"Fonseca-Aten M, Messina AF, Jafri HS, S\u00e1nchez PJ. Herpes simplex virus encephalitis during suppressive therapy with acyclovir in a premature infant. Pediatrics 2005;115:804\u20139.","journal-title":"Pediatrics"},{"key":"BFpr2016191_CR21","first-page":"371","volume":"22","author":"K Gutierrez","year":"2003","unstructured":"Gutierrez K, Arvin AM. Long term antiviral suppression after treatment for neonatal herpes infection. Pediatr Infect Dis J 2003;22:371\u20132.","journal-title":"Pediatr Infect Dis J"},{"key":"BFpr2016191_CR22","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1542\/peds.2004-1941","volume":"115","author":"LM Frenkel","year":"2005","unstructured":"Frenkel LM. Challenges in the diagnosis and management of neonatal herpes simplex virus encephalitis. Pediatrics 2005;115:795\u20137.","journal-title":"Pediatrics"},{"key":"BFpr2016191_CR23","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1056\/NEJMoa1003509","volume":"365","author":"DW Kimberlin","year":"2011","unstructured":"Kimberlin DW, Whitley RJ, Wan W, et al.; National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Oral acyclovir suppression and neurodevelopment after neonatal herpes. N Engl J Med 2011;365:1284\u201392.","journal-title":"N Engl J Med"},{"key":"BFpr2016191_CR24","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.jpeds.2014.11.011","volume":"166","author":"AJ Melvin","year":"2015","unstructured":"Melvin AJ, Mohan KM, Schiffer JT, et al. Plasma and cerebrospinal fluid herpes simplex virus levels at diagnosis and outcome of neonatal infection. J Pediatr 2015;166:827\u201333.","journal-title":"J Pediatr"},{"key":"BFpr2016191_CR25","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1093\/jac\/dkp083","volume":"63","author":"L Nassetta","year":"2009","unstructured":"Nassetta L, Kimberlin D, Whitley R. Treatment of congenital cytomegalovirus infection: implications for future therapeutic strategies. J Antimicrob Chemother 2009;63:862\u20137.","journal-title":"J Antimicrob Chemother"},{"key":"BFpr2016191_CR26","doi-asserted-by":"publisher","first-page":"B197","DOI":"10.1016\/j.vaccine.2012.10.074","volume":"31 Suppl 2","author":"P Griffiths","year":"2013","unstructured":"Griffiths P, Plotkin S, Mocarski E, et al. Desirability and feasibility of a vaccine against cytomegalovirus. Vaccine 2013;31 Suppl 2:B197\u2013203.","journal-title":"Vaccine"},{"key":"BFpr2016191_CR27","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1542\/peds.66.5.758","volume":"66","author":"RF Pass","year":"1980","unstructured":"Pass RF, Stagno S, Myers GJ, Alford CA. Outcome of symptomatic congenital cytomegalovirus infection: results of long-term longitudinal follow-up. Pediatrics 1980;66:758\u201362.","journal-title":"Pediatrics"},{"key":"BFpr2016191_CR28","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1001\/archpedi.1990.02150360091031","volume":"144","author":"WD Williamson","year":"1990","unstructured":"Williamson WD, Percy AK, Yow MD, et al. Asymptomatic congenital cytomegalovirus infection. Audiologic, neuroradiologic, and neurodevelopmental abnormalities during the first year. Am J Dis Child 1990;144:1365\u20138.","journal-title":"Am J Dis Child"},{"key":"BFpr2016191_CR29","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1542\/peds.90.6.862","volume":"90","author":"WD Williamson","year":"1992","unstructured":"Williamson WD, Demmler GJ, Percy AK, Catlin FI. Progressive hearing loss in infants with asymptomatic congenital cytomegalovirus infection. Pediatrics 1992;90:862\u20136.","journal-title":"Pediatrics"},{"key":"BFpr2016191_CR30","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1097\/00006454-199202000-00007","volume":"11","author":"SB Boppana","year":"1992","unstructured":"Boppana SB, Pass RF, Britt WJ, Stagno S, Alford CA. Symptomatic congenital cytomegalovirus infection: neonatal morbidity and mortality. Pediatr Infect Dis J 1992;11:93\u20139.","journal-title":"Pediatr Infect Dis J"},{"key":"BFpr2016191_CR31","unstructured":"Institute of Medicine. Vaccines for the 21st Century. Washington, DC: National Academy Press; 2000."},{"key":"BFpr2016191_CR32","first-page":"172","volume":"3","author":"A Carlson","year":"2010","unstructured":"Carlson A, Norwitz ER, Stiller RJ. Cytomegalovirus infection in pregnancy: should all women be screened? Rev Obstet Gynecol 2010;3:172\u20139.","journal-title":"Rev Obstet Gynecol"},{"key":"BFpr2016191_CR33","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.pcl.2012.12.008","volume":"60","author":"EC Swanson","year":"2013","unstructured":"Swanson EC, Schleiss MR. Congenital cytomegalovirus infection: new prospects for prevention and therapy. Pediatr Clin North Am 2013;60:335\u201349.","journal-title":"Pediatr Clin North Am"},{"key":"BFpr2016191_CR34","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.reprotox.2006.02.001","volume":"21","author":"E Mendelson","year":"2006","unstructured":"Mendelson E, Aboudy Y, Smetana Z, Tepperberg M, Grossman Z. Laboratory assessment and diagnosis of congenital viral infections: Rubella, cytomegalovirus (CMV), varicella-zoster virus (VZV), herpes simplex virus (HSV), parvovirus B19 and human immunodeficiency virus (HIV). Reprod Toxicol 2006;21:350\u201382.","journal-title":"Reprod Toxicol"},{"key":"BFpr2016191_CR35","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1056\/NEJM200105033441804","volume":"344","author":"SB Boppana","year":"2001","unstructured":"Boppana SB, Rivera LB, Fowler KB, Mach M, Britt WJ. Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity. N Engl J Med 2001;344:1366\u201371.","journal-title":"N Engl J Med"},{"key":"BFpr2016191_CR36","doi-asserted-by":"publisher","first-page":"S490","DOI":"10.1093\/clinids\/10.Supplement_3.S490","volume":"10 Suppl 3","author":"T Matthews","year":"1988","unstructured":"Matthews T, Boehme R. Antiviral activity and mechanism of action of ganciclovir. Rev Infect Dis 1988;10 Suppl 3:S490\u20134.","journal-title":"Rev Infect Dis"},{"key":"BFpr2016191_CR37","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/clpt.1993.4","volume":"53","author":"JM Trang","year":"1993","unstructured":"Trang JM, Kidd L, Gruber W, et al. Linear single-dose pharmacokinetics of ganciclovir in newborns with congenital cytomegalovirus infections. NIAID Collaborative Antiviral Study Group. Clin Pharmacol Ther 1993;53:15\u201321.","journal-title":"Clin Pharmacol Ther"},{"key":"BFpr2016191_CR38","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1128\/AAC.40.9.2202","volume":"40","author":"XJ Zhou","year":"1996","unstructured":"Zhou XJ, Gruber W, Demmler G, et al. Population pharmacokinetics of ganciclovir in newborns with congenital cytomegalovirus infections. NIAID Collaborative Antiviral Study Group. Antimicrob Agents Chemother 1996;40:2202\u20135.","journal-title":"Antimicrob Agents Chemother"},{"key":"BFpr2016191_CR39","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1086\/516445","volume":"175","author":"RJ Whitley","year":"1997","unstructured":"Whitley RJ, Cloud G, Gruber W, et al. Ganciclovir treatment of symptomatic congenital cytomegalovirus infection: results of a phase II study. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. J Infect Dis 1997;175:1080\u20136.","journal-title":"J Infect Dis"},{"key":"BFpr2016191_CR40","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/S0022-3476(03)00192-6","volume":"143","author":"DW Kimberlin","year":"2003","unstructured":"Kimberlin DW, Lin CY, S\u00e1nchez PJ, et al.; National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial. J Pediatr 2003;143:16\u201325.","journal-title":"J Pediatr"},{"key":"BFpr2016191_CR41","doi-asserted-by":"publisher","first-page":"S22","DOI":"10.1016\/j.jcv.2009.08.012","volume":"46 Suppl 4","author":"SE Oliver","year":"2009","unstructured":"Oliver SE, Cloud GA, S\u00e1nchez PJ, et al.; National Institute of Allergy, Infectious Diseases Collaborative Antiviral Study Group. Neurodevelopmental outcomes following ganciclovir therapy in symptomatic congenital cytomegalovirus infections involving the central nervous system. J Clin Virol 2009;46 Suppl 4:S22\u20136.","journal-title":"J Clin Virol"},{"key":"BFpr2016191_CR42","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1086\/528376","volume":"197","author":"DW Kimberlin","year":"2008","unstructured":"Kimberlin DW, Acosta EP, S\u00e1nchez PJ, et al.; National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Pharmacokinetic and pharmacodynamic assessment of oral valganciclovir in the treatment of symptomatic congenital cytomegalovirus disease. J Infect Dis 2008;197:836\u201345.","journal-title":"J Infect Dis"},{"key":"BFpr2016191_CR43","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1056\/NEJMoa1404599","volume":"372","author":"DW Kimberlin","year":"2015","unstructured":"Kimberlin DW, Jester PM, S\u00e1nchez PJ, et al.; National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Valganciclovir for symptomatic congenital cytomegalovirus disease. N Engl J Med 2015;372:933\u201343.","journal-title":"N Engl J Med"},{"key":"BFpr2016191_CR44","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1542\/peds.2008-2175","volume":"122","author":"American Academy of Pediatrics Committee on Pediatric AIDS.","year":"2008","unstructured":"American Academy of Pediatrics Committee on Pediatric AIDS. HIV testing and prophylaxis to prevent mother-to-child transmission in the United States. Pediatrics 2008;122:1127\u201334.","journal-title":"Pediatrics"},{"key":"BFpr2016191_CR45","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1097\/QAI.0b013e3181d90e8c","volume":"55","author":"Y Paramesparan","year":"2010","unstructured":"Paramesparan Y, Garvey LJ, Ashby J, Foster CJ, Fidler S, Winston A. High rates of asymptomatic neurocognitive impairment in vertically acquired HIV-1-infected adolescents surviving to adulthood. J Acquir Immune Defic Syndr 2010;55:134\u20136.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"BFpr2016191_CR46","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1542\/peds.2005-0804","volume":"117","author":"R Smith","year":"2006","unstructured":"Smith R, Malee K, Leighty R, et al.; Women and Infants Transmission Study Group. Effects of perinatal HIV infection and associated risk factors on cognitive development among young children. Pediatrics 2006;117:851\u201362.","journal-title":"Pediatrics"},{"key":"BFpr2016191_CR47","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1097\/INF.0b013e318253844b","volume":"31","author":"R Smith","year":"2012","unstructured":"Smith R, Chernoff M, Williams PL, et al.; Pediatric HIV\/AIDS Cohort Study (PHACS) Team. Impact of HIV severity on cognitive and adaptive functioning during childhood and adolescence. Pediatr Infect Dis J 2012;31:592\u20138.","journal-title":"Pediatr Infect Dis J"},{"key":"BFpr2016191_CR48","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1002\/rmv.1793","volume":"24","author":"CS Crowell","year":"2014","unstructured":"Crowell CS, Malee KM, Yogev R, Muller WJ. Neurologic disease in HIV-infected children and the impact of combination antiretroviral therapy. Rev Med Virol 2014;24:316\u201331.","journal-title":"Rev Med Virol"},{"key":"BFpr2016191_CR49","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1097\/QAI.0b013e3181b32646","volume":"52","author":"A Van Rie","year":"2009","unstructured":"Van Rie A, Dow A, Mupuala A, Stewart P. Neurodevelopmental trajectory of HIV-infected children accessing care in Kinshasa, Democratic Republic of Congo. J Acquir Immune Defic Syndr 2009;52:636\u201342.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"BFpr2016191_CR50","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1097\/QAD.0b013e328355d0ce","volume":"26","author":"B Laughton","year":"2012","unstructured":"Laughton B, Cornell M, Grove D, et al. Early antiretroviral therapy improves neurodevelopmental outcomes in infants. AIDS 2012;26:1685\u201390.","journal-title":"AIDS"},{"key":"BFpr2016191_CR51","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/QAD.0000000000000528","volume":"29","author":"CS Crowell","year":"2015","unstructured":"Crowell CS, Huo Y, Tassiopoulos K, et al.; PACTG 219C Study Team and the Pediatric HIVAIDS Cohort Study (PHACS). Early viral suppression improves neurocognitive outcomes in HIV-infected children. AIDS 2015;29:295\u2013304.","journal-title":"AIDS"},{"key":"BFpr2016191_CR52","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1093\/aje\/kwq320","volume":"172","author":"N Nathanson","year":"2010","unstructured":"Nathanson N, Kew OM. From emergence to eradication: the epidemiology of poliomyelitis deconstructed. Am J Epidemiol 2010;172:1213\u201329.","journal-title":"Am J Epidemiol"},{"key":"BFpr2016191_CR53","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.idc.2015.07.003","volume":"29","author":"JR Garon","year":"2015","unstructured":"Garon JR, Cochi SL, Orenstein WA. The challenge of global poliomyelitis eradication. Infect Dis Clin North Am 2015;29:651\u201365.","journal-title":"Infect Dis Clin North Am"},{"key":"BFpr2016191_CR54","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1097\/INF.0b013e3181a41d63","volume":"28","author":"TC Lee","year":"2009","unstructured":"Lee TC, Guo HR, Su HJ, Yang YC, Chang HL, Chen KT. Diseases caused by enterovirus 71 infection. Pediatr Infect Dis J 2009;28:904\u201310.","journal-title":"Pediatr Infect Dis J"},{"key":"BFpr2016191_CR55","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1056\/NEJMoa065954","volume":"356","author":"LY Chang","year":"2007","unstructured":"Chang LY, Huang LM, Gau SS, et al. Neurodevelopment and cognition in children after enterovirus 71 infection. N Engl J Med 2007;356:1226\u201334.","journal-title":"N Engl J Med"},{"key":"BFpr2016191_CR56","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1016\/S0140-6736(14)62457-0","volume":"385","author":"K Messacar","year":"2015","unstructured":"Messacar K, Schreiner TL, Maloney JA, et al. A cluster of acute flaccid paralysis and cranial nerve dysfunction temporally associated with an outbreak of enterovirus D68 in children in Colorado, USA. Lancet 2015;385:1662\u201371.","journal-title":"Lancet"},{"key":"BFpr2016191_CR57","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/S1473-3099(15)70093-9","volume":"15","author":"AL Greninger","year":"2015","unstructured":"Greninger AL, Naccache SN, Messacar K, et al. A novel outbreak enterovirus D68 strain associated with acute flaccid myelitis cases in the USA (2012-14): a retrospective cohort study. Lancet Infect Dis 2015;15:671\u201382.","journal-title":"Lancet Infect Dis"},{"key":"BFpr2016191_CR58","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1056\/NEJM199909233411302","volume":"341","author":"CC Huang","year":"1999","unstructured":"Huang CC, Liu CC, Chang YC, Chen CY, Wang ST, Yeh TF. Neurologic complications in children with enterovirus 71 infection. N Engl J Med 1999;341:936\u201342.","journal-title":"N Engl J Med"},{"key":"BFpr2016191_CR59","doi-asserted-by":"publisher","first-page":"21062","DOI":"10.2807\/1560-7917.ES2015.20.10.21062","volume":"20","author":"HC Pfeiffer","year":"2015","unstructured":"Pfeiffer HC, Bragstad K, Skram MK, et al. Two cases of acute severe flaccid myelitis associated with enterovirus D68 infection in children, Norway, autumn 2014. Euro Surveill 2015;20:21062.","journal-title":"Euro Surveill"},{"key":"BFpr2016191_CR60","doi-asserted-by":"publisher","first-page":"940","DOI":"10.15585\/mmwr.mm6434a3","volume":"64","author":"GR Abedi","year":"2015","unstructured":"Abedi GR, Watson JT, Pham H, Nix WA, Oberste MS, Gerber SI. Enterovirus and human parechovirus surveillance\u2013United States, 2009\u20132013. MMWR Morb Mortal Wkly Rep 2015;64:940\u20133.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"BFpr2016191_CR61","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1097\/00006454-199310000-00005","volume":"12","author":"MJ Abzug","year":"1993","unstructured":"Abzug MJ, Levin MJ, Rotbart HA. Profile of enterovirus disease in the first two weeks of life. Pediatr Infect Dis J 1993;12:820\u20134.","journal-title":"Pediatr Infect Dis J"},{"key":"BFpr2016191_CR62","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1128\/jvi.63.5.2002-2007.1989","volume":"63","author":"DC Pevear","year":"1989","unstructured":"Pevear DC, Fancher MJ, Felock PJ, et al. Conformational change in the floor of the human rhinovirus canyon blocks adsorption to HeLa cell receptors. J Virol 1989;63:2002\u20137.","journal-title":"J Virol"},{"key":"BFpr2016191_CR63","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1128\/AAC.43.9.2109","volume":"43","author":"DC Pevear","year":"1999","unstructured":"Pevear DC, Tull TM, Seipel ME, Groarke JM. Activity of pleconaril against enteroviruses. Antimicrob Agents Chemother 1999;43:2109\u201315.","journal-title":"Antimicrob Agents Chemother"},{"key":"BFpr2016191_CR64","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1086\/318452","volume":"32","author":"HA Rotbart","year":"2001","unstructured":"Rotbart HA, Webster AD ; Pleconaril Treatment Registry Group. Treatment of potentially life-threatening enterovirus infections with pleconaril. Clin Infect Dis 2001;32:228\u201335.","journal-title":"Clin Infect Dis"},{"key":"BFpr2016191_CR65","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1097\/00006454-200009000-00005","volume":"19","author":"GL Kearns","year":"2000","unstructured":"Kearns GL, Bradley JS, Jacobs RF, et al. Single dose pharmacokinetics of pleconaril in neonates. Pediatric pharmacology research unit network. Pediatr Infect Dis J 2000;19:833\u20139.","journal-title":"Pediatr Infect Dis J"},{"key":"BFpr2016191_CR66","first-page":"335","volume":"22","author":"MJ Abzug","year":"2003","unstructured":"Abzug MJ, Cloud G, Bradley J, et al.; National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Double blind placebo-controlled trial of pleconaril in infants with enterovirus meningitis. Pediatr Infect Dis J 2003;22:335\u201341.","journal-title":"Pediatr Infect Dis J"},{"key":"BFpr2016191_CR67","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1093\/jpids\/piv015","volume":"5","author":"MJ Abzug","year":"2016","unstructured":"Abzug MJ, Michaels MG, Wald E, et al.; National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. A randomized, double-blind, placebo-controlled trial of pleconaril for the treatment of neonates with enterovirus sepsis. J Pediatric Infect Dis Soc 2016;5:53\u201362.","journal-title":"J Pediatric Infect Dis Soc"},{"key":"BFpr2016191_CR68","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1093\/jpids\/piv030","volume":"5","author":"JF Modlin","year":"2016","unstructured":"Modlin JF. Treatment of neonatal enterovirus infections. J Pediatric Infect Dis Soc 2016;5:63\u20134.","journal-title":"J Pediatric Infect Dis Soc"},{"key":"BFpr2016191_CR69","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1056\/NEJMsr1604338","volume":"374","author":"SA Rasmussen","year":"2016","unstructured":"Rasmussen SA, Jamieson DJ, Honein MA, Petersen LR. Zika virus and birth defects\u2013reviewing the evidence for causality. N Engl J Med 2016;374:1981\u20137.","journal-title":"N Engl J Med"},{"key":"BFpr2016191_CR70","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1111\/j.1365-3156.2004.01253.x","volume":"9","author":"E Depoortere","year":"2004","unstructured":"Depoortere E, Kavle J, Keus K, Zeller H, Murri S, Legros D. Outbreak of West Nile virus causing severe neurological involvement in children, Nuba Mountains, Sudan, 2002. Trop Med Int Health 2004;9:730\u20136.","journal-title":"Trop Med Int Health"},{"key":"BFpr2016191_CR71","doi-asserted-by":"publisher","first-page":"898","DOI":"10.3109\/00365540903225179","volume":"41","author":"G Venturi","year":"2009","unstructured":"Venturi G, El-Sawaf G, Arpino C, et al. Arboviral infections in Egyptian and Sardinian children and adults with aseptic meningitis and meningo-encephalitis. Scand J Infect Dis 2009;41:898\u20139.","journal-title":"Scand J Infect Dis"},{"key":"BFpr2016191_CR72","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/S0002-9394(03)00452-5","volume":"136","author":"SG Alpert","year":"2003","unstructured":"Alpert SG, Fergerson J, No\u00ebl LP. Intrauterine West Nile virus: ocular and systemic findings. Am J Ophthalmol 2003;136:733\u20135.","journal-title":"Am J Ophthalmol"},{"key":"BFpr2016191_CR73","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1177\/0883073808314151","volume":"23","author":"S Robin","year":"2008","unstructured":"Robin S, Ramful D, Le Seach\u2019 F, Jaffar-Bandjee MC, Rigou G, Alessandri JL. Neurologic manifestations of pediatric chikungunya infection. J Child Neurol 2008;23:1028\u201335.","journal-title":"J Child Neurol"},{"key":"BFpr2016191_CR74","first-page":"9","volume":"81","author":"A Mathur","year":"1985","unstructured":"Mathur A, Tandon HO, Mathur KR, Sarkari NB, Singh UK, Chaturvedi UC. Japanese encephalitis virus infection during pregnancy. Indian J Med Res 1985;81:9\u201312.","journal-title":"Indian J Med Res"},{"key":"BFpr2016191_CR75","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1093\/infdis\/141.6.712","volume":"141","author":"UC Chaturvedi","year":"1980","unstructured":"Chaturvedi UC, Mathur A, Chandra A, Das SK, Tandon HO, Singh UK. Transplacental infection with Japanese encephalitis virus. J Infect Dis 1980;141:712\u20135.","journal-title":"J Infect Dis"},{"key":"BFpr2016191_CR76","first-page":"63","volume":"23","author":"LW Gauld","year":"1979","unstructured":"Gauld LW, McMillan BC, Sinha SK. Relationship of California group virus infection and mental retardation: seroepidemiological observations. J Ment Defic Res 1979;23:63\u20138.","journal-title":"J Ment Defic Res"},{"issue":"5 Pt 5","key":"BFpr2016191_CR77","first-page":"513","volume":"84","author":"L Poli","year":"1991","unstructured":"Poli L, Chungue E, Soulignac O, Gestas P, Kuo P, Papouin-Rauzy M. [Materno-fetal dengue. Apropos of 5 cases observed during the epidemic in Tahiti (1989)]. Bull Soc Pathol Exot 1991;84(5 Pt 5):513\u201321.","journal-title":"Bull Soc Pathol Exot"},{"key":"BFpr2016191_CR78","first-page":"488","volume":"32","author":"A Kerdpanich","year":"2001","unstructured":"Kerdpanich A, Watanaveeradej V, Samakoses R, et al. Perinatal dengue infection. Southeast Asian J Trop Med Public Health 2001;32:488\u201393.","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"BFpr2016191_CR79","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1097\/INF.0b013e318167917a","volume":"27","author":"W Phongsamart","year":"2008","unstructured":"Phongsamart W, Yoksan S, Vanaprapa N, Chokephaibulkit K. Dengue virus infection in late pregnancy and transmission to the infants. Pediatr Infect Dis J 2008;27:500\u20134.","journal-title":"Pediatr Infect Dis J"},{"key":"BFpr2016191_CR80","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1086\/516126","volume":"25","author":"JK Chye","year":"1997","unstructured":"Chye JK, Lim CT, Ng KB, Lim JM, George R, Lam SK. Vertical transmission of dengue. Clin Infect Dis 1997;25:1374\u20137.","journal-title":"Clin Infect Dis"},{"key":"BFpr2016191_CR81","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1128\/JVI.01849-12","volume":"87","author":"SJ Kopp","year":"2013","unstructured":"Kopp SJ, Karaba AH, Cohen LK, Banisadr G, Miller RJ, Muller WJ. Pathogenesis of neonatal herpes simplex 2 disease in a mouse model is dependent on entry receptor expression and route of inoculation. J Virol 2013;87:474\u201381.","journal-title":"J Virol"},{"key":"BFpr2016191_CR82","doi-asserted-by":"publisher","first-page":"e00437","DOI":"10.1128\/mBio.00437-16","volume":"7","author":"DR Wilcox","year":"2016","unstructured":"Wilcox DR, Folmsbee SS, Muller WJ, Longnecker R. The type I interferon response determines differences in choroid plexus susceptibility between newborns and adults in herpes simplex virus encephalitis. MBio 2016;7:e00437\u201316.","journal-title":"MBio"},{"key":"BFpr2016191_CR83","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/pr.2014.135","volume":"76","author":"SJ Kopp","year":"2014","unstructured":"Kopp SJ, Ranaivo HR, Wilcox DR, Karaba AH, Wainwright MS, Muller WJ. Herpes simplex virus serotype and entry receptor availability alter CNS disease in a mouse model of neonatal HSV. Pediatr Res 2014;76:528\u201334.","journal-title":"Pediatr Res"},{"key":"BFpr2016191_CR84","doi-asserted-by":"publisher","first-page":"e1004580","DOI":"10.1371\/journal.ppat.1004580","volume":"11","author":"DR Wilcox","year":"2015","unstructured":"Wilcox DR, Wadhwani NR, Longnecker R, Muller WJ. Differential reliance on autophagy for protection from HSV encephalitis between newborns and adults. PLoS Pathog 2015;11:e1004580.","journal-title":"PLoS Pathog"},{"key":"BFpr2016191_CR85","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/nature11866","volume":"494","author":"S Shoji-Kawata","year":"2013","unstructured":"Shoji-Kawata S, Sumpter R, Leveno M, et al. Identification of a candidate therapeutic autophagy-inducing peptide. Nature 2013;494:201\u20136.","journal-title":"Nature"},{"key":"BFpr2016191_CR86","doi-asserted-by":"publisher","first-page":"12407","DOI":"10.1128\/JVI.02090-13","volume":"87","author":"X Zhang","year":"2013","unstructured":"Zhang X, Zheng Z, Shu B, et al. Human astrocytic cells support persistent coxsackievirus B3 infection. J Virol 2013;87:12407\u201321.","journal-title":"J Virol"},{"key":"BFpr2016191_CR87","doi-asserted-by":"publisher","first-page":"e1004774","DOI":"10.1371\/journal.ppat.1004774","volume":"11","author":"RD Bradford","year":"2015","unstructured":"Bradford RD, Yoo YG, Golemac M, Pugel EP, Jonjic S, Britt WJ. Murine CMV-induced hearing loss is associated with inner ear inflammation and loss of spiral ganglia neurons. PLoS Pathog 2015;11:e1004774.","journal-title":"PLoS Pathog"},{"key":"BFpr2016191_CR88","doi-asserted-by":"publisher","first-page":"12172","DOI":"10.1128\/JVI.01214-08","volume":"82","author":"D Cekinovi\u0107","year":"2008","unstructured":"Cekinovi\u0107 D, Golemac M, Pugel EP, et al. Passive immunization reduces murine cytomegalovirus-induced brain pathology in newborn mice. J Virol 2008;82:12172\u201380.","journal-title":"J Virol"},{"key":"BFpr2016191_CR89","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1097\/01.LAB.0000032376.58688.D4","volume":"82","author":"H Kawasaki","year":"2002","unstructured":"Kawasaki H, Kosugi I, Arai Y, Tsutsui Y. The amount of immature glial cells in organotypic brain slices determines the susceptibility to murine cytomegalovirus infection. Lab Invest 2002;82:1347\u201358.","journal-title":"Lab Invest"},{"key":"BFpr2016191_CR90","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1093\/infdis\/170.5.1267","volume":"170","author":"SD Poland","year":"1994","unstructured":"Poland SD, Bambrick LL, Dekaban GA, Rice GP. The extent of human cytomegalovirus replication in primary neurons is dependent on host cell differentiation. J Infect Dis 1994;170:1267\u201371.","journal-title":"J Infect Dis"},{"key":"BFpr2016191_CR91","doi-asserted-by":"publisher","first-page":"8842","DOI":"10.1128\/JVI.76.17.8842-8854.2002","volume":"76","author":"AN van den Pol","year":"2002","unstructured":"van den Pol AN, Reuter JD, Santarelli JG. Enhanced cytomegalovirus infection of developing brain independent of the adaptive immune system. J Virol 2002;76:8842\u201354.","journal-title":"J Virol"},{"key":"BFpr2016191_CR92","doi-asserted-by":"publisher","first-page":"670","DOI":"10.3109\/13550289909021295","volume":"5","author":"CK Petito","year":"1999","unstructured":"Petito CK, Chen H, Mastri AR, Torres-Munoz J, Roberts B, Wood C. HIV infection of choroid plexus in AIDS and asymptomatic HIV-infected patients suggests that the choroid plexus may be a reservoir of productive infection. J Neurovirol 1999;5:670\u20137.","journal-title":"J Neurovirol"},{"key":"BFpr2016191_CR93","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1097\/01.aids.0000166090.31693.aa","volume":"19","author":"EJ Burkala","year":"2005","unstructured":"Burkala EJ, He J, West JT, Wood C, Petito CK. Compartmentalization of HIV-1 in the central nervous system: role of the choroid plexus. AIDS 2005;19:675\u201384.","journal-title":"AIDS"},{"key":"BFpr2016191_CR94","doi-asserted-by":"publisher","first-page":"9356","DOI":"10.1128\/JVI.02382-07","volume":"83","author":"R Feuer","year":"2009","unstructured":"Feuer R, Ruller CM, An N, et al. Viral persistence and chronic immunopathology in the adult central nervous system following Coxsackievirus infection during the neonatal period. J Virol 2009;83:9356\u201369.","journal-title":"J Virol"},{"key":"BFpr2016191_CR95","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/labinvest.2013.138","volume":"94","author":"JM Puccini","year":"2014","unstructured":"Puccini JM, Ruller CM, Robinson SM, et al. Distinct neural stem cell tropism, early immune activation, and choroid plexus pathology following coxsackievirus infection in the neonatal central nervous system. Lab Invest 2014;94:161\u201381.","journal-title":"Lab Invest"},{"key":"BFpr2016191_CR96","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/S0002-9440(10)63496-7","volume":"163","author":"R Feuer","year":"2003","unstructured":"Feuer R, Mena I, Pagarigan RR, Harkins S, Hassett DE, Whitton JL. Coxsackievirus B3 and the neonatal CNS: the roles of stem cells, developing neurons, and apoptosis in infection, viral dissemination, and disease. Am J Pathol 2003;163:1379\u201393.","journal-title":"Am J Pathol"},{"key":"BFpr2016191_CR97","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.stem.2016.03.012","volume":"18","author":"TJ Nowakowski","year":"2016","unstructured":"Nowakowski TJ, Pollen AA, Di Lullo E, Sandoval-Espinosa C, Bershteyn M, Kriegstein AR. Expression analysis highlights AXL as a candidate Zika virus entry receptor in neural stem cells. Cell Stem Cell 2016;18:591\u20136.","journal-title":"Cell Stem Cell"},{"key":"BFpr2016191_CR98","doi-asserted-by":"publisher","first-page":"S151","DOI":"10.1038\/nature16028","volume":"527","author":"D Silberberg","year":"2015","unstructured":"Silberberg D, Anand NP, Michels K, Kalaria RN. Brain and other nervous system disorders across the lifespan\u2014global challenges and opportunities. Nature 2015;527:S151\u20134.","journal-title":"Nature"},{"key":"BFpr2016191_CR99","doi-asserted-by":"publisher","first-page":"S167","DOI":"10.1038\/nature16031","volume":"527","author":"GL Birbeck","year":"2015","unstructured":"Birbeck GL, Meyer AC, Ogunniyi A. Nervous system disorders across the life course in resource-limited settings. Nature 2015;527:S167\u201371.","journal-title":"Nature"},{"key":"BFpr2016191_CR100","doi-asserted-by":"publisher","first-page":"S178","DOI":"10.1038\/nature16033","volume":"527","author":"CC John","year":"2015","unstructured":"John CC, Carabin H, Montano SM, Bangirana P, Zunt JR, Peterson PK. Global research priorities for infections that affect the nervous system. Nature 2015;527:S178\u201386.","journal-title":"Nature"}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/pr2016191.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/pr2016191","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/pr.2016.191","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.nature.com\/articles\/pr2016191.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,16]],"date-time":"2022-04-16T09:10:32Z","timestamp":1650100232000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/pr2016191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,27]]},"references-count":100,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["BFpr2016191"],"URL":"https:\/\/doi.org\/10.1038\/pr.2016.191","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,27]]},"assertion":[{"value":"20 April 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}